Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 173

1.

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials.

Shi Q, Flowers CR, Hiddemann W, Marcus R, Herold M, Hagenbeek A, Kimby E, Hochster H, Vitolo U, Peterson BA, Gyan E, Ghielmini M, Nielsen T, De Bedout S, Fu T, Valente N, Fowler NH, Hoster E, Ladetto M, Morschhauser F, Zucca E, Salles G, Sargent DJ.

J Clin Oncol. 2016 Dec 28:JCO2016708651. [Epub ahead of print]

PMID:
28029309
2.

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).

Morrison VA, Weller EA, Habermann TM, Li S, Fisher RI, Cheson BD, Peterson BA.

Leuk Lymphoma. 2017 Aug;58(8):1814-1822. doi: 10.1080/10428194.2016.1265111. Epub 2016 Dec 14.

PMID:
27967294
3.

Self-Fertility in a Cultivated Diploid Potato Population Examined with the Infinium 8303 Potato Single-Nucleotide Polymorphism Array.

Peterson BA, Holt SH, Laimbeer FP, Doulis AG, Coombs J, Douches DS, Hardigan MA, Buell CR, Veilleux RE.

Plant Genome. 2016 Nov;9(3). doi: 10.3835/plantgenome2016.01.0003.

4.

Genome-Wide Assessment of Efficiency and Specificity in CRISPR/Cas9 Mediated Multiple Site Targeting in Arabidopsis.

Peterson BA, Haak DC, Nishimura MT, Teixeira PJ, James SR, Dangl JL, Nimchuk ZL.

PLoS One. 2016 Sep 13;11(9):e0162169. doi: 10.1371/journal.pone.0162169. eCollection 2016.

5.

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.

Maurer MJ, Jais JP, Ghesquières H, Witzig TE, Hong F, Haioun C, Thompson CA, Thieblemont C, Micallef IN, Porrata LF, Ribrag V, Nowakowski GS, Casasnovas O, Bologna S, Morschhauser F, Morrison VA, Peterson BA, Macon WR, Copie-Bergman C, Feldman AL, Syrbu SI, Kurtin PJ, Gascoyne RD, Li H, Allmer C, Kahl BS, Ansell SM, Slager SL, Link BK, Salles G, Habermann TM, Tilly H, Cerhan JR.

Am J Hematol. 2016 Feb;91(2):179-84. doi: 10.1002/ajh.24223. Epub 2015 Nov 26.

6.

CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types.

Migueles SA, Mendoza D, Zimmerman MG, Martins KM, Toulmin SA, Kelly EP, Peterson BA, Johnson SA, Galson E, Poropatich KO, Patamawenu A, Imamichi H, Ober A, Rehm CA, Jones S, Hallahan CW, Follmann DA, Connors M.

EBioMedicine. 2014 Dec 22;2(1):46-58. doi: 10.1016/j.ebiom.2014.12.009. eCollection 2015 Jan.

7.

Plant stem cell maintenance by transcriptional cross-regulation of related receptor kinases.

Nimchuk ZL, Zhou Y, Tarr PT, Peterson BA, Meyerowitz EM.

Development. 2015 Mar 15;142(6):1043-9. doi: 10.1242/dev.119677.

8.

Lymphoma of the hands in a patient with rheumatoid arthritis: case report.

Gordon MJ, Peterson BA, Skubitz KM.

J Hand Surg Am. 2014 Apr;39(4):728-31. doi: 10.1016/j.jhsa.2014.01.034. Epub 2014 Mar 5.

PMID:
24612835
9.

Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected].

Graf EH, Pace MJ, Peterson BA, Lynch LJ, Chukwulebe SB, Mexas AM, Shaheen F, Martin JN, Deeks SG, Connors M, Migueles SA, O'Doherty U.

PLoS One. 2013 Aug 7;8(8):e71879. doi: 10.1371/journal.pone.0071879. eCollection 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/3aa92c3d-b6dd-4c6e-8cee-9587ce80a9c9.

10.

Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.

Jaklitsch MT, Gu L, Demmy T, Harpole DH, D'Amico TA, McKenna RJ, Krasna MJ, Kohman LJ, Swanson SJ, DeCamp MM, Wang X, Barry S, Sugarbaker DJ; CALGB Thoracic Surgeons.

J Thorac Cardiovasc Surg. 2013 Jul;146(1):9-16. doi: 10.1016/j.jtcvs.2012.12.069.

11.

New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.

Walker A, Mrózek K, Kohlschmidt J, Rao KW, Pettenati MJ, Sterling LJ, Marcucci G, Carroll AJ, Bloomfield CD; Alliance for Clinical Trials in Oncology.

Genes Chromosomes Cancer. 2013 Apr;52(4):385-401. doi: 10.1002/gcc.22036. Epub 2012 Dec 10.

12.

Comprehensive analysis of unique cases with extraordinary control over HIV replication.

Mendoza D, Johnson SA, Peterson BA, Natarajan V, Salgado M, Dewar RL, Burbelo PD, Doria-Rose NA, Graf EH, Greenwald JH, Hodge JN, Thompson WL, Cogliano NA, Chairez CL, Rehm CA, Jones S, Hallahan CW, Kovacs JA, Sereti I, Sued O, Peel SA, O'Connell RJ, O'Doherty U, Chun TW, Connors M, Migueles SA.

Blood. 2012 May 17;119(20):4645-55. doi: 10.1182/blood-2011-10-381996. Epub 2012 Apr 5.

13.

Pilot study of vascular health in survivors of Hodgkin lymphoma.

Mulrooney DA, Ness KK, Solovey A, Hebbel RP, Neaton JD, Peterson BA, Lee CK, Kelly AS, Neglia JP.

Pediatr Blood Cancer. 2012 Aug;59(2):285-9. doi: 10.1002/pbc.24082. Epub 2012 Mar 27.

14.

Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.

Monk JP, Halabi S, Picus J, Hussain A, Philips G, Kaplan E, Ahles T, Gu L, Vogelzang N, Kelly WK, Small EJ; Cancer and Leukemia Group B.

Cancer. 2012 Sep 1;118(17):4139-47. doi: 10.1002/cncr.26732. Epub 2011 Dec 16.

15.

Use of family history in clinical guidelines for diabetes and colorectal cancer.

Peterson BA, Gwinn ML, Valdez RA.

Am J Prev Med. 2012 Jan;42(1):65-70. doi: 10.1016/j.amepre.2011.08.017.

PMID:
22176849
16.

Castleman disease and associated autoimmune disease.

Muskardin TW, Peterson BA, Molitor JA.

Curr Opin Rheumatol. 2012 Jan;24(1):76-83. doi: 10.1097/BOR.0b013e32834db525. Review.

PMID:
22157415
17.

Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).

Romanus D, Kindler HL, Archer L, Basch E, Niedzwiecki D, Weeks J, Schrag D; Cancer and Leukemia Group B.

J Pain Symptom Manage. 2012 Feb;43(2):205-17. doi: 10.1016/j.jpainsymman.2011.09.001. Epub 2011 Nov 21.

18.

Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.

Blaes AH, Ma L, Zhang Y, Peterson BA.

Leuk Lymphoma. 2011 Nov;52(11):2105-10. doi: 10.3109/10428194.2011.593270. Epub 2011 Jul 8.

19.

Effects of floor space during transport and journey time on indicators of stress and transport losses of market-weight pigs.

Pilcher CM, Ellis M, Rojo-Gómez A, Curtis SE, Wolter BF, Peterson CM, Peterson BA, Ritter MJ, Brinkmann J.

J Anim Sci. 2011 Nov;89(11):3809-18. doi: 10.2527/jas.2010-3143. Epub 2011 May 13.

20.

Effect of feed withdrawal and dietary energy source on muscle glycolytic potential and blood acid-base responses to handling in slaughter-weight pigs.

Bertol TM, Braña DV, Ellis M, Ritter MJ, Peterson BA, Mendoza OF, McKeith FK.

J Anim Sci. 2011 May;89(5):1561-73. doi: 10.2527/jas.2010-2942.

Supplemental Content

Loading ...
Support Center